Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Letter

Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis

Online download statistics by month:

Online download statistics by month: January 2022 to March 2024

	Abstract	Full	Pdf
Jan 2022	5118	5164	436
Feb 2022	760	759	104
Mar 2022	628	627	122
Apr 2022	378	389	142
May 2022	180	182	41
Jun 2022	118	118	26
Jul 2022	131	128	51
Aug 2022	105	98	33
Sep 2022	152	158	22
Oct 2022	92	92	35
Nov 2022	71	70	18
Dec 2022	81	75	29
Jan 2023	62	60	32
Feb 2023	66	63	18
Mar 2023	54	52	22
Apr 2023	141	9	7
May 2023	79	4	2
Jun 2023	182	3	1
Jul 2023	90	11	7
Aug 2023	79	5	4
Sep 2023	150	10	4
Oct 2023	120	5	5
Nov 2023	124	6	8
Dec 2023	110	10	6
Jan 2024	81	4	5
Feb 2024	46	0	1
Mar 2024	156	2	5
Total	9354	8104	1186